Abbott Laboratories Stock Plunges on Nutrition Division Struggles and Weak Guidance

Abbott (ABT) stock fell 8% after missing Q4 earnings expectations, with nutrition sales dropping 8.9% due to lower volumes and strategic price cuts on baby formula and supplements.